Takeda broke into the list of top 20 publicly traded innovative pharma companies after its $62 billion merger with Shire earlier this year, according to a new analysis using market capitali
Germany’s Evotec has announced another high-profile R&D partnership with big pharma, beginning a multi-year R&D partnership with Takeda, focusing on discovering small molecule drugs
Patients in England and Wales with hereditary angioedema (HAE) should soon have a new treatment option after NICE recommended Takeda’s Takhzyro (lanadelumab) should be funded by the NHS in